BridgeMD
New treatment option for Fracture
Official title Buprenorphine for Analgesia in Older Adults With Acute Fractures in the Emergency Department
ClinicalTrials.gov ID: NCT07430345
What this study is testing
What is Buprenorphine 0.15 MG?
Buprenorphine 0.15 MG is an investigational medicine, being studied as a potential treatment for fracture.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The goal of this clinical trial is to learn if buprenorphine can treat pain in older adults who have broken bones. The main questions it aims to answer are: Is buprenorphine as effective as opioids to treat pain?
- Phase 2: a mid-size study of how well it works
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 65 and older
You may be able to join if
- Age 65 years or older
- Emergency Department patient
- Diagnosis of suspected or confirmed acute fracture
- Numerical Rating Scale 4 or greater at time of presentation
- Must be able to give informed consent or have a surrogate decisionmaker to provide informed consent
You likely can't join if
- Prior history of opioid use disorder
- Participants taking chronic opioid therapy (defined as opioids taken during the past month)
- Allergy to study medications
- Hemodynamic instability requiring immediate resuscitation
- Inability to consent and absence of surrogate decisionmaker
See the full eligibility criteria
- Age 65 years or older
- Emergency Department patient
- Diagnosis of suspected or confirmed acute fracture
- Numerical Rating Scale 4 or greater at time of presentation
- Must be able to give informed consent or have a surrogate decisionmaker to provide informed consent
- people who may require a surgical procedure are eligible for enrollment, as given the low dose of buprenorphine, this is not anticipated to affect future anesthesia. If additional pain control is needed for surgical...
- Prior history of opioid use disorder
- Participants taking chronic opioid therapy (defined as opioids taken during the past month)
- Allergy to study medications
- Hemodynamic instability requiring immediate resuscitation
- Inability to consent and absence of surrogate decisionmaker
The study team makes the final eligibility decision.
Where it's taking place
- Camden, New Jersey, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 65 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Camden, New Jersey, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.